Andrea H Weinberger1, Mehmet Sofuoglu. 1. Program for Research on Smokers with Mental Illness (PRISM), Substance Abuse Center, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. andrea.weinberger@yale.edu
Abstract
OBJECTIVES: Stimulant users smoke cigarettes at high rates; however, little is known about the relationship between tobacco and stimulants. METHODS: Our goal in this article is to synthesize a growing literature on the role of cigarette smoking in stimulant addiction. RESULTS: Early nicotine exposure may influence the development of stimulant addiction. Preclinical and clinical studies suggest a facilitatory role of nicotinic agonists for stimulant addiction. Smoking appears to be associated with more severe stimulant use and poorer treatment outcomes. CONCLUSIONS: It is important to assess smoking and smoking-related variables within stimulant research studies to more fully understand the comorbidity. Integrating smoking cessation into stimulant treatment may improve nicotine and stimulant treatment outcomes.
OBJECTIVES: Stimulant users smoke cigarettes at high rates; however, little is known about the relationship between tobacco and stimulants. METHODS: Our goal in this article is to synthesize a growing literature on the role of cigarette smoking in stimulant addiction. RESULTS: Early nicotine exposure may influence the development of stimulant addiction. Preclinical and clinical studies suggest a facilitatory role of nicotinic agonists for stimulant addiction. Smoking appears to be associated with more severe stimulant use and poorer treatment outcomes. CONCLUSIONS: It is important to assess smoking and smoking-related variables within stimulant research studies to more fully understand the comorbidity. Integrating smoking cessation into stimulant treatment may improve nicotine and stimulant treatment outcomes.
Authors: Mischa de Rover; Johannes C Lodder; Karel S Kits; Anton N M Schoffelmeer; Arjen B Brussaard Journal: Eur J Neurosci Date: 2002-12 Impact factor: 3.386
Authors: Ashwin A Patkar; Michael J Vergare; Charles C Thornton; Stephen P Weinstein; Heather W Murray; Frank T Leone Journal: Nicotine Tob Res Date: 2003-06 Impact factor: 4.244
Authors: Ashwin A Patkar; Allan Lundy; Frank T Leone; Stephen P Weinstein; Edward Gottheil; Michael Steinberg Journal: Subst Abus Date: 2002-06 Impact factor: 3.716
Authors: Anna B Konova; Scott J Moeller; Dardo Tomasi; Muhammad A Parvaz; Nelly Alia-Klein; Nora D Volkow; Rita Z Goldstein Journal: Eur J Neurosci Date: 2012-07-09 Impact factor: 3.386
Authors: Young-Hoon Sung; Deborah A Yurgelun-Todd; Douglas G Kondo; Xian-Feng Shi; Kelly J Lundberg; Tracy L Hellem; Rebekah S Huber; Erin C McGlade; Eun-Kee Jeong; Perry F Renshaw Journal: Am J Drug Alcohol Abuse Date: 2015-04-14 Impact factor: 3.829
Authors: Angelica M Morales; Buyean Lee; Gerhard Hellemann; Joseph O'Neill; Edythe D London Journal: Drug Alcohol Depend Date: 2012-03-22 Impact factor: 4.492
Authors: David H Epstein; Gina F Marrone; Stephen J Heishman; John Schmittner; Kenzie L Preston Journal: Addict Behav Date: 2009-11-12 Impact factor: 3.913